Six months double blind study in patients with Friedreich ataxia

• Research type

  Research Study

• Full title

  A six-month double-blind, randomized, placebo-controlled study investigating the safety and tolerability of deferiprone in patients with Friedreich’s ataxia

• Contact name

  Anthony Schapira

• Contact email

  anthony.schapira@royalfree.nhs.uk

• Sponsor organisation

  ApoPharma Inc.

• Eudract number

  2007-003331-23

• Clinicaltrials.gov Identifier

  NCT00530127

• REC name

  London - Hampstead Research Ethics Committee

• REC reference

  08/H0720/112

• Date of REC Opinion

  20 Nov 2008

• REC opinion

  Further Information Favourable Opinion